10-K Filing

BIO-TECHNE CORP CIK: 842023 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001437749-21-020980`
Period End Date	20210630
Filing Date	20210825
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	tech20200630b_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 94 Income Statement 78 Cash Flow Statement 116 Stockholders Equity 46

Balance Sheet 94 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.23M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$775.00K	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Undesignated capital stock, no par (in dollars per share)	`UndesignatedCapitalStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$146.62M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.09M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$124.27M	USD	Point-in-time
Undesignated capital stock, shares authorized (in shares)	`UndesignatedCapitalStockSharesAuthorized`	5.00M	shares	Point-in-time
Short-term available-for-sale investments	`AvailableForSaleSecuritiesCurrent`	$32.46M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,229 and $775, respectively	`AccountsReceivableNetCurrent`	$122.53M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $1,229 and $775, respectively	`AccountsReceivableNetCurrent`	$145.38M	USD	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Undesignated capital stock, shares issued (in shares)	`UndesignatedCapitalStockSharesIssued`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$103.15M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$116.75M	USD	Point-in-time
Undesignated capital stock, shares outstanding (in shares)	`UndesignatedCapitalStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.92M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$24.34M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$510.61M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$520.92M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.45M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$207.91M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	38.96M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$176.83M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.96M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	38.45M	shares	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$71.47M	USD	Point-in-time
Right of use asset	`OperatingLeaseRightOfUseAsset`	$73.83M	USD	Point-in-time
Goodwill	`Goodwill`	$732.67M	USD	Point-in-time
Goodwill	`Goodwill`	$728.31M	USD	Point-in-time
Goodwill	`Goodwill`	$843.07M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$516.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$579.43M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$615.97M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$13.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.57M	USD	Point-in-time
Total assets	`Assets`	$2.03B	USD	Point-in-time
Total assets	`Assets`	$2.26B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$23.09M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$29.38M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$51.29M	USD	Point-in-time
Salaries, wages and related accruals	`EmployeeRelatedLiabilitiesCurrent`	$31.09M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$15.28M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.09M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$13.05M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$19.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$5.34M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.38M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$11.60M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$9.54M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$4.00M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$5.94M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Current portion of long-term debt obligations	`LongTermDebtCurrent`	$12.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.89M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$152.28M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$106.67M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$93.12M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$101.09M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$328.83M	USD	Point-in-time
Long-term debt obligations	`LongTermDebtAndCapitalLeaseObligations`	$344.24M	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$199.00K	USD	Point-in-time
Long-term contingent consideration payable	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$25.40M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.62M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.25M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$26.95M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$24.46M	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding	`UndesignatedCapitalStockValue`	-	USD	Point-in-time
Common stock, par value $.01 a share; authorized 100,000,000 shares; issued and outstanding 38,955,484 and 38,453,046 shares, respectively	`CommonStockValue`	$385.00K	USD	Point-in-time
Common stock, par value $.01 a share; authorized 100,000,000 shares; issued and outstanding 38,955,484 and 38,453,046 shares, respectively	`CommonStockValue`	$390.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$420.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$534.41M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.06B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.09B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-97.20M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-57.29M	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.38B	USD	Point-in-time
Total Bio-Techne shareholders' equity	`StockholdersEquity`	$1.56B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$8.26M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.17B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.26B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$2.03B	USD	Point-in-time

Income Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$738.69M	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$714.01M	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$931.03M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$240.51M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$298.18M	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$255.50M	USD	Annual
Gross margin	`GrossProfit`	$632.85M	USD	Annual
Gross margin	`GrossProfit`	$473.49M	USD	Annual
Gross margin	`GrossProfit`	$483.19M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$260.58M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$264.36M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$324.95M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$65.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$70.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$62.41M	USD	Annual
Total operating expenses	`OperatingExpenses`	$395.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$326.77M	USD	Annual
Total operating expenses	`OperatingExpenses`	$325.77M	USD	Annual
Operating income	`OperatingIncomeLoss`	$237.30M	USD	Annual
Operating income	`OperatingIncomeLoss`	$157.42M	USD	Annual
Operating income	`OperatingIncomeLoss`	$146.72M	USD	Annual
Interest expense	`InterestExpense`	$13.95M	USD	Annual
Interest expense	`InterestExpense`	$21.70M	USD	Annual
Interest expense	`InterestExpense`	$19.20M	USD	Annual
Interest income	`InvestmentIncomeNet`	$473.00K	USD	Annual
Interest income	`InvestmentIncomeNet`	$605.00K	USD	Annual
Interest income	`InvestmentIncomeNet`	$569.00K	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-75.64M	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$-13.57M	USD	Annual
Other non-operating income (expense), net	`OtherNonoperatingIncomeExpense`	$137.65M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-89.12M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$119.06M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-34.70M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$148.18M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$112.02M	USD	Annual
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$276.48M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$15.94M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$47.18M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$8.59M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$229.30M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$139.59M	USD	Annual
Net earnings, including noncontrolling interest	`ProfitLoss`	$96.07M	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-825.00K	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net earnings (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$140.41M	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$229.30M	USD	Annual
Net earnings attributable to Bio-Techne	`NetIncomeLoss`	$96.07M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$32.95M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-9.96M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-4.49M	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8.	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$7.06M	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8.	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-9.54M	USD	Annual
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8.	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-3.71M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$40.01M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-14.02M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-13.68M	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	-	USD	Annual
Other comprehensive income (loss) attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$103.00K	USD	Annual
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-13.68M	USD	Annual
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$39.91M	USD	Annual
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-14.02M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$215.62M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$180.32M	USD	Annual
Comprehensive income attributable to Bio-Techne	`ComprehensiveIncomeNetOfTax`	$82.05M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.62	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$6.00	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.54	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.82	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.47	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.47	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.20M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.78M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	38.75M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	39.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.89M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.48M	shares	Annual

Cash Flow Statement 116 line items

Line Item	Tag	Value	Unit	Period
Net earnings, including non-controlling interest	`ProfitLoss`	$229.30M	USD	Annual
Net earnings, including non-controlling interest	`ProfitLoss`	$139.59M	USD	Annual
Net earnings, including non-controlling interest	`ProfitLoss`	$96.07M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$78.17M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$82.74M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$87.75M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$1.56M	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	-	USD	Annual
Costs recognized on sale of acquired inventory	`FairValueWriteUpOfAcquiredInventory`	$3.74M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-13.58M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-27.43M	USD	Annual
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$13.13M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$32.37M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$32.28M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$48.98M	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-905.00K	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$-2.00M	USD	Annual
Fair value adjustment to contingent consideration payable	`FairValueAdjustmentToContingentConsiderationPayable`	$5.30M	USD	Annual
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-958.00K	USD	Annual
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-337.00K	USD	Annual
Contingent consideration payments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	Annual
(Gain) Loss on investment, net	`GainOnSaleOfInvestments`	-	USD	Annual
(Gain) Loss on investment, net	`GainOnSaleOfInvestments`	-	USD	Annual
(Gain) Loss on investment, net	`GainOnSaleOfInvestments`	$3.70M	USD	Annual
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$67.88M	USD	Annual
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$16.07M	USD	Annual
Fair value adjustment on available for sale investments	`FairValueAdjustmentOnAvailableForSaleSecurities`	$-137.53M	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	$75.00K	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	-	USD	Annual
Leases, net	`NoncashPortionOfLeaseExpense`	$225.00K	USD	Annual
Gain on escrow settlement	`GainLossOnEscrowSettlement`	-	USD	Annual
Gain on escrow settlement	`GainLossOnEscrowSettlement`	$7.17M	USD	Annual
Gain on escrow settlement	`GainLossOnEscrowSettlement`	-	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-732.00K	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$2.33M	USD	Annual
Other operating activity	`OtherOperatingActivitiesCashFlowStatement`	$-464.00K	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$15.00M	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-6.56M	USD	Annual
Trade accounts and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$15.55M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$14.86M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$7.14M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$13.65M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$2.60M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$698.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.10M	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$19.09M	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$10.34M	USD	Annual
Trade accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$6.10M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$20.54M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$2.55M	USD	Annual
Salaries, wages and related accruals	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$5.01M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$13.43M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-9.52M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-7.23M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$205.22M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$352.16M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$181.62M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$66.38M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$21.58M	USD	Annual
Proceeds from sale and maturities of available-for-sale investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$147.12M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$43.48M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$39.68M	USD	Annual
Purchase of available-for-sale investments	`PaymentsToAcquireAvailableForSaleSecurities`	$70.19M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.41M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.30M	USD	Annual
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.74M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$225.35M	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$289.49M	USD	Annual
Investment in unconsolidated entity, net	`InvestmentInUnconsolidatedEntity`	$-1.91M	USD	Annual
Investment in unconsolidated entity, net	`InvestmentInUnconsolidatedEntity`	$556.00K	USD	Annual
Investment in unconsolidated entity, net	`InvestmentInUnconsolidatedEntity`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-336.80M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-243.52M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$27.09M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$49.62M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$48.36M	USD	Annual
Cash dividends	`PaymentsOfDividendsCommonStock`	$48.90M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$70.98M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$37.95M	USD	Annual
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$65.09M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$50.11M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$43.18M	USD	Annual
Re-purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$15.40M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$256.00M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$580.00M	USD	Annual
Borrowings under line-of-credit agreement	`ProceedsFromLongTermLinesOfCredit`	$40.00M	USD	Annual
Payments on line-of-credit	`RepaymentsOfLinesOfCredit`	$413.50M	USD	Annual
Payments on line-of-credit	`RepaymentsOfLinesOfCredit`	$271.50M	USD	Annual
Payments on line-of-credit	`RepaymentsOfLinesOfCredit`	$188.50M	USD	Annual
Contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.40M	USD	Annual
Contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	Annual
Contingent consideration payments	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-19.34M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-6.30M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.87M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-183.80M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$134.38M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-62.55M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-308.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$6.37M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-2.77M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$45.74M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.10M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$52.47M	USD	Annual
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$121.99M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$199.09M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$121.99M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$100.89M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$146.62M	USD	Point-in-time

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Balances (in shares)	`CommonStockSharesOutstanding`	38.96M	shares	Point-in-time
Balances (in shares)	`CommonStockSharesOutstanding`	38.45M	shares	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.17B	USD	Point-in-time
Net earnings	`ProfitLoss`	$229.30M	USD	Annual
Net earnings	`ProfitLoss`	$139.59M	USD	Annual
Net earnings	`ProfitLoss`	$96.07M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$40.01M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-14.02M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-13.68M	USD	Annual
Share repurchases (in shares)	`StockRepurchasedDuringPeriodShares`	279,381.00	shares	Annual
Share repurchases (in shares)	`StockRepurchasedDuringPeriodShares`	120,000.00	shares	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$43.18M	USD	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$50.11M	USD	Annual
Share repurchases	`StockRepurchasedDuringPeriodValue`	$15.40M	USD	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	627,000.00	shares	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	743,000.00	shares	Annual
Common stock issued for exercise of options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	383,000.00	shares	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$49.82M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$36.28M	USD	Annual
Common stock issued for exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$67.83M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-2.23M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-2.58M	USD	Annual
Common stock issued for restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-7.06M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$48.36M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$49.62M	USD	Annual
Cash dividends	`DividendsCommonStockCash`	$48.90M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$48.06M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.93M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.77M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.31M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$2.79M	USD	Annual
Common stock issued to employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.68M	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$505.00K	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$917.00K	USD	Annual
Employee stock purchase plan expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$435.00K	USD	Annual
Surrender and retirement of stock to exercise option	`SurrenderAndRetirementOfStockToExerciseOptionsValue`	$-400.00K	USD	Annual
Non-controlling interest in Eminence	`NoncontrollingInterestIncreaseFromBusinessCombination`	$8.98M	USD	Annual
Balances (in shares)	`CommonStockSharesOutstanding`	38.96M	shares	Point-in-time
Balances (in shares)	`CommonStockSharesOutstanding`	38.45M	shares	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.38B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.57B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.17B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.